Third Harmonic Bio, Inc.
THRDDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001923840
Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Third Harmonic Bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +10 vs. Q3 2022
- Shares held
- 35.6M
- +149.0K (+0.4%) vs. Q3 2022
- Total value
- $153.1M
- −$519.7M (−77.2%) vs. Q3 2022
- New holders
- 28
- 6 more added
- Sold out
- 18
- 10 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $110.0K |
| Q1 2026 | 4 | $110.0K |
| Q4 2025 | 4 | $111.5K |
| Q3 2025 | 18 | $1.19M |
| Q2 2025 | 107 | $210.2M |
| Q1 2025 | 100 | $134.4M |
| Q4 2024 | 98 | $462.5M |
| Q3 2024 | 85 | $596.6M |
| Q2 2024 | 77 | $523.2M |
| Q1 2024 | 71 | $357.6M |
| Q4 2023 | 62 | $416.0M |
| Q3 2023 | 56 | $241.5M |
| Q2 2023 | 48 | $173.5M |
| Q1 2023 | 49 | $149.7M |
| Q4 2022 | 50 | $153.1M |
| Q3 2022 | 40 | $672.8M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Third Harmonic Bio, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 109 | $469 | 0.00% | +109 | New |
| Point72 Middle East FZE | 171 | $735 | 0.00% | +171 | New |
| Citigroup Inc | 414 | $1.78K | 0.00% | +414 | New |
| Ameritas Investment Partners, Inc. | 1,010 | $4.32K | 0.00% | +1,010 | New |
| Legal & General Group Plc | 1,199 | $5.14K | 0.00% | +1,199 | New |
| Amalgamated Bank | 1,481 | $6.00K | 0.00% | +1,481 | New |
| Tower Research Capital LLC (TRC) | 1,666 | $7.00K | 0.00% | +1,666 | New |
| Royal Bank of Canada | 2,021 | $9.00K | 0.00% | −3,536−63.6% | Reduced |
| STRS Ohio | 2,900 | $12.0K | 0.00% | +2,900 | New |
| Barclays PLC | 3,394 | $14.6K | 0.00% | −25,356−88.2% | Reduced |
| California State Teachers Retirement System | 5,046 | $21.7K | 0.00% | +5,046 | New |
| Deutsche Bank AG | 5,447 | $23.4K | 0.00% | +5,447 | New |
| American International Group, Inc. | 5,979 | $25.7K | 0.00% | +5,979 | New |
| UBS Group AG | 7,061 | $30.4K | 0.00% | +5,809+464.0% | Added |
| LPL Financial LLC | 10,000 | $43.0K | 0.00% | +10,000 | New |
| Cubist Systematic Strategies, LLC | 10,489 | $45.1K | 0.00% | −72−0.7% | Reduced |
| Rhumbline Advisers | 10,635 | $46.0K | 0.00% | +10,635 | New |
| Bank of America Corp | 12,197 | $52.4K | 0.00% | +12,197 | New |
| Squarepoint Ops LLC | 13,912 | $59.8K | 0.00% | −11,472−45.2% | Reduced |
| New York State Common Retirement Fund | 14,300 | $61.5K | 0.00% | +14,300 | New |
| Caas Capital Management LP | 16,000 | $68.8K | 0.01% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 17,476 | $75.0K | 0.00% | +17,476 | New |
| JPMorgan Chase & Co | 18,878 | $81.0K | 0.00% | +18,878 | New |
| Manufacturers Life Insurance Company, The | 28,141 | $118.2K | 0.00% | +7,375+35.5% | Added |
| TD Asset Management Inc | 32,767 | $140.9K | 0.00% | +32,767 | New |
| Bank of New York Mellon Corp | 37,094 | $159.5K | 0.00% | +37,094 | New |
| Morgan Stanley | 46,535 | $200.1K | 0.00% | +39,375+549.9% | Added |
| Walleye Capital LLC | 56,900 | $244.7K | 0.01% | +56,900 | New |
| Charles Schwab Investment Management Inc | 87,555 | $376.5K | 0.00% | +87,555 | New |
| HighVista Strategies LLC | 91,780 | $394.7K | 0.23% | +91,780 | New |
| Northern Trust Corp | 102,933 | $442.6K | 0.00% | +102,933 | New |
| State Street Corp | 194,430 | $836.0K | 0.00% | +194,430 | New |
| Geode Capital Management, LLC | 230,610 | $991.0K | 0.00% | +230,610 | New |
| Millennium Management LLC | 271,255 | $1.17M | 0.00% | +92,954+52.1% | Added |
| Wellington Management Group LLP | 340,460 | $1.46M | 0.00% | −828,094−70.9% | Reduced |
| Deep Track Capital, LP | 445,572 | $1.92M | 0.08% | −822,648−64.9% | Reduced |
| Price T Rowe Associates Inc | 457,327 | $1.97M | 0.00% | −13,299−2.8% | Reduced |
| Ra Capital Management, L.P. | 534,687 | $2.30M | 0.05% | −2,941,000−84.6% | Reduced |
| Boxer Capital, LLC | 570,417 | $2.45M | 0.13% | 00.0% | Unchanged |
| RTW Investments, LP | 609,687 | $2.62M | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 696,370 | $2.99M | 0.00% | +596,370+596.4% | Added |
| BlackRock Inc. | 748,748 | $3.22M | 0.00% | +748,748 | New |
| Commodore Capital LP | 993,294 | $4.27M | 0.64% | −25,275−2.5% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 1,151,657 | $4.95M | 0.55% | −1,128,425−49.5% | Reduced |
| Tang Capital Management LLC | 1,700,000 | $7.31M | 1.06% | +1,700,000 | New |
| Stonepine Capital Management, LLC | 2,015,301 | $8.67M | 3.65% | +2,015,301 | New |
| General Atlantic LLC | 2,958,762 | $12.7M | 0.17% | 00.0% | Unchanged |
| BVF Inc | 4,365,933 | $18.8M | 0.79% | +864,119+24.7% | Added |
| OrbiMed Advisors LLC | 5,779,071 | $24.9M | 0.48% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $46.9M | 5.65% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −200,063−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −58,465−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −57,687−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −54,500−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −27,800−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −19,099−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −18,809−100.0% | Sold out |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −17,825−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −11,596−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |